Back to search results
Completed

Mild Cognitive Impairment, Mild Alzheimer's

A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

LMDA | {{ defaultRegistry.registryAnchorText }} NCT02754830 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The purpose of this study is to evaluate the safety and tolerability of the study drug, LY3303560, administered either intravenously or subcutaneously, in both healthy participants and patients with Alzheimer's disease. Side effects and laboratory results will be monitored.

Completed Study

The results of this study are not yet available.

Time Commitment

Your participation could last up to 16 weeks and include 11 visits to the study center, including a 4 day clinical research unit (CRU) stay.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

30+ years
  • Healthy participants must be of non-childbearing potential

  • Alzheimer's disease (AD) participants must be at least 50 years of age

  • Alzheimer's disease (AD) participants must have either mild cognitive impairment (MCI) or mild-to-moderate AD and have a positive PET scan

  • Participants must not have an increased risk of seizures

Where This Study Took Place Tool Tip Icon

Where This Study Took Place Tool Tip Icon

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.